MedPath

Remote Ischemic Preconditioning Mechanism Study

Early Phase 1
Completed
Conditions
Pain
Interventions
Device: Remote Ischemic Preconditioning, Capsaicin, UV-B
Registration Number
NCT01541436
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

This research is being done because pain is a significant problem for patients with a variety of medical problems and following surgery or traumatic injury. Currently available pain medications may not relieve all types of pain or may relieve pain only at doses that produce side effects and potential complications.

Although Remote Ischemic Preconditioning (RIPC) appears promising, there remain several unanswered questions about how it works. This research trial will help determine how RIPC may activate the bodies natural pain control system. The goals of this study are to see if RIPC has any effect 1) on a small area of skin that will be expose to a small amount of UV- B radiation (a mild sunburn), 2) on acute thermal heat temperatures that will be applied to skin, and 3) on the sunburn-like sensation to light touch after putting capsaicin cream (the active ingredient in hot chili peppers) on skin.

Remote ischemic preconditioning is done by inflating a balloon (very similar to a blood pressure cuff) on the leg until it blocks blood flow for a few minutes. The cuff is then deflated and blood flow resumes. The process is repeated up to three times. This procedure causes the body to increase its natural pain relief system that may help to decrease the amount of postsurgical pain.

Detailed Description

The purpose of this pilot study is to determine whether RIPC effects peripheral sensitization, central sensitization or both and determine effect size since there is no data regarding the presumed effect. These issues cannot be easily sorted out in patients experiencing postoperative pain and hypersensitivity, since surgery affects both components. In order to address this purpose the investigators will examine, in healthy volunteers, the effect of RIPC on a manipulation which generates hypersensitivity by an exclusive peripheral mechanism (ultraviolet B (UV-B) burn) and a manipulation which generates hypersensitivity by an exclusive central mechanism (topical capsaicin). Understanding the sites at which RIPC reduces the amplification of pain after injury will be useful in determining where it would be most logically applied clinically and in guiding preclinical mechanistic studies.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • healthy volunteers of both sexes ASA 1 or II classification
  • between the ages of 18-55
  • weighing less than 250 pounds
  • without chronic pain
  • not taking analgesics
  • off caffeine for 2 days.
Exclusion Criteria
  • pregnancy
  • allergy to capsaicin
  • lower extremity vascular insufficiency
  • active treatment for DVT
  • severe thigh pain
  • taking psychotropic medications, including anti-depressants.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Capsaicin, UV-B, RIPCRemote Ischemic Preconditioning, Capsaicin, UV-B-
Capsaicin, UV-BRemote Ischemic Preconditioning, Capsaicin, UV-B-
Primary Outcome Measures
NameTimeMethod
Areas of hyperalgesia and allodynia to mechanical stimuli.24 hours

Hyperalgesia will be measured with vonFrey fibers and allodynia will be measured with a cotton wisp. The area will be measured in cm2.

Secondary Outcome Measures
NameTimeMethod
Pain intensity and unpleasantness to mechanical stimuli24 hours

Using a Visual Analog Sliding Scale the intensity and unpleasantness will be measured in centimeters.

Presence of parathesias where RIPC was used24 hours

After a brief tourniquet application I fully expect participants to have some degree of parasthesias. Using a standard rating scale I will record and report this.

Trial Locations

Locations (1)

WakeForestUBMC

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath